Full Text
EE120 Assessing the Potential Cost Effectiveness of Cell Therapy Adjuvant to Surgery for Hirschsprung Disease

Abstract

Authors

S. AlHathlool S. Dixon

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×